5 Shocking Insights From Martin Shkreli On FDA’s New CBER Head And Pharma’s Future
Martin Shkreli, often referred to as the “Pharma Bro,” has once again stirred the pot with his controversial opinions on the pharmaceutical industry. Recently, he expressed his thoughts about Vinay Prasad, the new head of the FDA’s Center for Biologics Evaluation and Research (CBER), labeling him as “nuts.” Shkreli’s comments have ignited discussions about the … Read more